Review article · 2025 · Open access
Bridging the digital divide in the pharmaceutical industry: A future research agenda
Social Science & Medicine, 389, 118832 · Published 28 November 2025 · DOI 10.1016/j.socscimed.2025.118832
In brief
“Bridging the digital divide in the pharmaceutical industry: A future research agenda” is a 2025 review article by Mario Miozza and 3 co-authors, published in Social Science & Medicine. OpenAlex counts 11 citations as of 18 November 2026, which puts it in the top 2% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Social Science & Medicine.
- Citations
- 11
- Most cited in
- 2026 (10)
- Field-weighted impact
- 1.26
- References
- 121
- Authors
- 4
Abstract
Digital transformation is reshaping the pharmaceutical industry, but adoption remains fragmented due to regulatory constraints, organizational inertia, and unequal digital capabilities. This study investigates how the digital divide influences the implementation of new technologies across the pharmaceutical value chain. We combined a systematic literature review of 70 peer-reviewed studies with topic modeling (Latent Dirichlet Allocation) to provide an integrated overview of challenges, opportunities, and future research directions. Our analysis identified 16 thematic clusters consolidated into five strategic domains: Advancing Drug Discovery, Reinventing Organizational Strategies, Optimizing Manufacturing, Strengthening Supply Chains, and Developing Patient-Centric Models. The results show that digital transformation is not only a technical matter but also a systemic process shaped by regulation, governance, and socio-economic conditions. While artificial intelligence, blockchain, digital twins, and other technologies hold potential to accelerate innovation and improve patient outcomes, their benefits are distributed unevenly. Large multinational firms, advanced laboratories, and well-resourced health systems are better positioned to adopt these tools, while small and medium enterprises, emerging economies, and marginalized patient groups often face barriers in infrastructure, expertise, and compliance. From these findings, we developed a structured research agenda to bridge the pharmaceutical digital divide. Priorities include clarifying regulatory and institutional frameworks for digital technologies, identifying the organizational capabilities and governance models required for systemic adoption, and addressing equity implications to ensure inclusive access across geographies, firms, and patient populations. This study contributes methodologically by integrating systematic review and topic modeling, conceptually by framing digital transformation through a value-chain and digital divide perspective, and practically by offering a roadmap for managers, policymakers, and scholars.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Miozza, M., Lombardo, S. M., Galvagno, M., & Magni, L. (2025). Bridging the digital divide in the pharmaceutical industry: A future research agenda. Social Science & Medicine, 389, 118832. https://doi.org/10.1016/j.socscimed.2025.118832
MLA 9
Miozza, Mario, et al. “Bridging the digital divide in the pharmaceutical industry: A future research agenda.” Social Science & Medicine, vol. 389, 2025, p. 118832. https://doi.org/10.1016/j.socscimed.2025.118832.
Chicago
Miozza, Mario, Salvatore M. Lombardo, Marco Galvagno, and Luca Magni. 2025. “Bridging the digital divide in the pharmaceutical industry: A future research agenda.” Social Science & Medicine 389: 118832. https://doi.org/10.1016/j.socscimed.2025.118832.
Harvard
Miozza, M. et al. (2025) ‘Bridging the digital divide in the pharmaceutical industry: A future research agenda’, Social Science & Medicine, 389, p. 118832. doi:10.1016/j.socscimed.2025.118832.
IEEE
M. Miozza, S. M. Lombardo, M. Galvagno, and L. Magni, “Bridging the digital divide in the pharmaceutical industry: A future research agenda,” Social Science & Medicine, vol. 389, p. 118832, 2025, doi: 10.1016/j.socscimed.2025.118832.
BibTeX
@article{miozza2025bridging,
title = {{Bridging the digital divide in the pharmaceutical industry: A future research agenda}},
author = {Miozza, Mario and Lombardo, Salvatore M. and Galvagno, Marco and Magni, Luca},
journal = {Social Science \& Medicine},
year = {2025},
volume = {389},
pages = {118832},
doi = {10.1016/j.socscimed.2025.118832},
url = {https://doi.org/10.1016/j.socscimed.2025.118832}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Business, Management and Accounting › Management of Technology and Innovation › Digital Innovation in Industries
- digital divide
- pharmaceutical industry
- digital transformation
- technology adoption
- pharmaceutical value chain
- drug discovery
- pharmaceutical manufacturing
- supply chain
Work with this paper
Most-cited papers in Business, Management and Accounting
- Firm Resources and Sustained Competitive AdvantageJay Bryan Barney · Journal of Management · 1991 · 57,081 citations
- The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational FieldsPaul DiMaggio, Walter W. Powell · American Sociological Review · 1983 · 42,816 citations
- Building Theories from Case Study ResearchKathleen M. Eisenhardt · Academy of Management Review · 1989 · 39,809 citations
- Firm resources and sustained competitive advantageJay Bryan Barney · Advances in strategic management · 2004 · 38,183 citations
- Absorptive Capacity: A New Perspective on Learning and InnovationWesley M. Cohen, Daniel A. Levinthal · Administrative Science Quarterly · 1990 · 37,030 citations
Questions about this paper
How do I cite this paper in APA style?
Miozza, M., Lombardo, S. M., Galvagno, M., & Magni, L. (2025). Bridging the digital divide in the pharmaceutical industry: A future research agenda. Social Science & Medicine, 389, 118832. https://doi.org/10.1016/j.socscimed.2025.118832
How many times has this paper been cited?
11 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Social Science & Medicine: sign in and open the full text from this page.
Who wrote this paper?
Mario Miozza, Salvatore M. Lombardo, Marco Galvagno, Luca Magni.
What is the DOI of this paper?
10.1016/j.socscimed.2025.118832, permanently at https://doi.org/10.1016/j.socscimed.2025.118832. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.